Obesity: Appetite drug could mark 'new era' in tackling condition – BBC News

Jan took part in the trial

A drug that suppresses urge for food has led to some individuals shedding greater than a fifth of their physique weight, a serious worldwide trial reveals.

A weekly injection of the drug, semaglutide, was given alongside recommendation on food plan and health.

The examine, carried out on virtually 2,000 individuals, confirmed a mean 15kg weight reduction throughout the 15-month trial.

Scientists stated the outcomes might mark a “new period” in treating weight problems with much more therapies on the horizon.

Jan, from Kent, misplaced 28kg (4 stone), equal to greater than a fifth of her physique weight.

“The drug modified my life and fully altered my strategy to meals,” she stated.

She stated weight-reduction plan had made her “depressing” however taking the drug was fully completely different as she was much less hungry.


Nevertheless, now Jan has come off the trial her urge for food has returned and he or she is placing weight again on.

She stated: “It felt easy losing a few pounds whereas on the trial, however now it has gone again to feeling like a relentless battle with meals.”

Semaglutide will already be acquainted to some individuals who use it as a remedy for sort 2 diabetes, however this trial checked out giving it at greater doses.

  • Tesco urged by buyers to promote extra wholesome meals

The drug works by hijacking the physique’s urge for food ranges and mimicking a hormone – known as GLP1 – that’s launched after consuming a filling meal.

The trial gave some individuals the drug and others a dummy injection, whereas each teams got the life-style recommendation.

The outcomes, revealed within the New England Journal of Medication, confirmed individuals misplaced a mean of 15kg on semaglutide in contrast with 2.6kg with out.

Nevertheless, 32% of individuals misplaced a fifth of their physique weight with the drug, in contrast with fewer than 2% on the dummy remedy.

‘New period’

Prof Rachel Batterham, from UCL and one of many UK researchers, informed the BBC Information web site: “This can be a game-changer within the quantity of weight reduction it causes.

“I’ve spent the final 20 years doing weight problems analysis, up till now we have not had an efficient remedy for weight problems aside from bariatric surgical procedure.”

She stated losing a few pounds would scale back the chance of coronary heart illness, diabetes and of extreme Covid-19.

Semaglutide is being submitted to medicine regulators so can’t be routinely prescribed. Nevertheless, Prof Batterham expects the drug can be used initially by specialist weight reduction clinics reasonably than being extensively out there.

There have been side-effects to the remedy together with nausea, diarrhoea, vomiting, and constipation. And there are five-year research happening to see if weight reduction could be sustained in the long run.

Prof Sir Stephen O’Rahilly, from the College of Cambridge, stated: “The quantity of weight reduction achieved is larger than that seen with any licensed anti-obesity drug.

“That is the beginning of a brand new period for weight problems drug improvement with the long run path being to realize ranges of weight reduction similar to semaglutide, whereas having fewer side-effects.”

Dr Duane Mellor, a dietician and from Aston Medical Faculty, stated: “It’s helpful to have a possible choice to assist individuals shed some pounds, nevertheless we have to acknowledge that weight reduction will nonetheless want life-style change, and that any medicine or change in life-style can carry potential dangers and side-effects.

“So, it’s at all times clever to talk to a well being skilled earlier than attempting to shed some pounds.”

Observe James on Twitter

Let’s block advertisements! (Why?)

Related Post

Leave a Reply

Your email address will not be published.